An LPS test detects lipopolysaccharide, a potentially dangerous molecule shed by certain bacteria, in pharmaceuticals, medical devices, water systems, and sometimes in a patient’s blood. The test exists because even trace amounts of LPS can trigger fever, inflammation, organ damage, or fatal shock when they enter the bloodstream. Most people encounter LPS testing indirectly: every injectable drug, every IV fluid bag, and every implantable medical device must pass an LPS test before reaching you. The science behind the test, the surprising biology it relies on, and the growing debate over how it should be done in the future are all worth understanding.
What LPS Actually Is
LPS stands for lipopolysaccharide, a large molecule embedded in the outer membrane of Gram-negative bacteria. When those bacteria die or multiply, fragments of LPS break free. In medical and pharmaceutical contexts, LPS is called an “endotoxin” because the toxin is a structural part of the bacterium itself rather than something the bacterium secretes. The toxic punch comes from a specific portion of the molecule called lipid A, which anchors the rest of the structure into the bacterial membrane. Research on the relationship between lipid A’s shape and its biological effects has shown that the number of fatty acid chains, the length of those chains, and even where phosphate groups sit on the molecule all change how strongly it activates the human immune system.1PubMed. Structure, Function and Biological Activity of Lipopolysaccharide Lipid A
When LPS enters your bloodstream, your immune cells recognize lipid A as a danger signal and launch an aggressive inflammatory response. In small doses that means fever, which is why LPS is classified as a “pyrogen” (a fever-causing substance). In larger doses or in vulnerable patients, the cascade can spiral into septic shock. This is why pharmaceutical regulators around the world demand proof that injectable products are essentially free of endotoxin before they reach patients.
How the Classic LAL Test Works
The workhorse of LPS detection for decades has been the Limulus Amebocyte Lysate test, usually called the LAL test. It relies on a remarkable quirk of horseshoe crab biology. Horseshoe crabs have an open circulatory system and no adaptive immune system, so they evolved a different defense: their blood cells, called amebocytes, contain a cascade of clotting proteins that react almost instantly to bacterial endotoxin. When amebocytes encounter LPS, they release these proteins, which trigger a chain reaction that ends in a visible clot. In the wild, this seals wounds and traps invading bacteria. In the lab, it becomes a detection system.
To make the reagent, manufacturers harvest horseshoe crab blood, isolate the amebocytes, and break them open to collect the lysate. This lysate is then freeze-dried into a standardized reagent. When a sample suspected of containing endotoxin is mixed with the reagent, the clotting cascade activates through a protein called Factor C. If a gel forms or a color change occurs, endotoxin is present.2BIO Web of Conferences. Research progress of limulus coagulation mechanism and limulus reagents
The LAL test replaced an older and far less pleasant method: injecting samples into rabbits and watching for fever. That rabbit pyrogen test was the standard for most of the twentieth century. The LAL test is far more sensitive to endotoxin than the rabbit test, yet it still took roughly 25 to 30 years of validation before regulators fully accepted it as a replacement.3PubMed. History of the LAL-test: validation and regulatory acceptance
Three Flavors of the LAL Test
Not all LAL tests look the same. The reagent is the same horseshoe crab lysate, but the way results are read differs, and each method has trade-offs.
- Gel-clot method: The simplest version. You mix sample and reagent in a tube, incubate it, then tip the tube. If a firm gel has formed, endotoxin is present above the test’s sensitivity threshold. It gives a yes-or-no answer rather than a precise number.
- Chromogenic method: A synthetic color-producing substrate is added to the reagent. When the clotting cascade activates, the final enzyme in the chain cleaves the substrate and releases a yellow compound. The intensity of the color, measured with a spectrophotometer, corresponds to how much endotoxin is in the sample.
- Turbidimetric method: Instead of color, this version tracks how cloudy the mixture becomes over time. The speed at which turbidity develops is proportional to endotoxin concentration.
A comparative study of all three methods applied to the same product found that the absolute endotoxin values they reported could differ substantially from one another, even though each method accurately detected known amounts of spiked endotoxin within its own system.4PubMed. A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin This means labs need to stick with one validated method for a given product rather than mixing and matching.
Where LPS Testing Is Required
The bacterial endotoxin test is a mandatory quality-control step across the pharmaceutical and medical device industries. Every batch of an injectable drug, from a simple saline bag to a complex biologic, must demonstrate that endotoxin levels fall below established safety limits before it can be released. Those limits vary by the route of administration and by pharmacopeia. A review of endotoxin standards across the United States Pharmacopeia, European Pharmacopoeia, Japanese Pharmacopoeia, British Pharmacopoeia, Indian Pharmacopoeia, and the International Pharmacopoeia found both similarities and meaningful differences in permissible limits and acceptance criteria, highlighting an ongoing push for global harmonization.5Journal of Biological Methods. A comparative analysis of pharmacopeial quality standards for antibiotics with respect to bacterial endotoxin limits
Dialysis water is another major testing ground. Patients on hemodialysis have blood flowing across a membrane in close contact with dialysis fluid for hours at a time. If that fluid contains endotoxin, it can cross the membrane and trigger chronic inflammation. European guidelines set a tight limit for standard dialysis water and an even tighter one for “ultrapure” dialysate used in high-flux dialysis. A study of Lithuanian hemodialysis centers found that all water and dialysate samples fell below the standard limit, though a small fraction exceeded the stricter ultrapure threshold.6PubMed. The level of endotoxins in hemodialysis water and dialysate A separate study found that about a third of ultrapure dialysis fluid samples tested exceeded recommended international standards for endotoxin, suggesting that not every facility keeps contamination reliably in check.7Bionatura. Endotoxin quality of ultrapure dialysis fluid for online hemodiafiltration in several hemodialysis centers
LPS Testing in the Clinic
Beyond pharmaceutical quality control, LPS testing has a role in clinical medicine, particularly in the diagnosis and management of sepsis. The Endotoxin Activity Assay (EAA) is a whole-blood test designed for use at the bedside. It measures how strongly a patient’s neutrophils respond to added endotoxin, producing results on a scale from 0 (no activity) to 1 (maximal activity). The manufacturer recommends classifying results as low (below 0.4), intermediate (0.4 to 0.59), or high (0.60 and above). These categories are based on a large observational study that included healthy controls, though the clinical interpretation of specific values remains debated, and the proportional distribution of sepsis patients across the three tiers has not been firmly established.8PubMed Central. Clinical applications for the endotoxin activity assay in sepsis: a scoping review
In neonatal medicine, where late-onset sepsis is a serious concern in premature infants, endotoxin detection has shown promise as a diagnostic tool alongside blood cultures. A study of 160 neonatal samples found that an endotoxin test achieved about 84% sensitivity, 78% specificity, and 81% overall diagnostic accuracy, with results available faster than traditional blood cultures.9PubMed. Diagnostic Accuracy of Endotoxin and Endotoxin Binding Protein in Late-Onset Neonatal Sepsis Blood cultures remain the gold standard for confirming infection, but an endotoxin test can flag high-risk babies more quickly, allowing earlier treatment decisions.
Veterinary medicine uses the same principles. A portable test system for detecting endotoxin activity in bovine serum showed strong correlation with traditional LAL-based chromogenic and turbidimetric assays, making it a practical field tool for diagnosing endotoxemia in cattle.10PubMed Central. Detecting endotoxin activity in bovine serum using an automated testing system
Things That Can Go Wrong With the Test
The LAL test is sensitive, but it is not foolproof. One well-known limitation is that the horseshoe crab lysate reacts to more than just endotoxin. A second pathway in the clotting cascade, driven by a protein called Factor G, is activated by beta-glucan, a component of fungal cell walls. That means fungal contamination can trigger a positive LAL result even when no bacterial endotoxin is present. This cross-reactivity matters in settings where fungal infections are common, such as intensive care units, and it has to be accounted for when interpreting results.
A subtler problem emerged more recently in biopharmaceutical manufacturing. Certain product formulations, particularly those containing nonionic surfactants and metal-chelating agents, can cause a phenomenon called Low Endotoxin Recovery, or LER. When endotoxin is spiked into these formulations and the mixture sits for a period of time, the detectable endotoxin activity drops dramatically.11PubMed Central. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon This is not a case of the test itself failing; rather, the product’s ingredients physically alter the structure of LPS so that it no longer binds efficiently to Factor C in the lysate. Research has shown that the process is driven by temperature and requires both a surfactant and a chelating agent acting together to reshape the endotoxin’s structure.12PubMed. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems The practical worry is that a contaminated drug could pass its endotoxin test simply because the drug’s own ingredients masked the contamination.
Even the anticoagulant heparin, commonly present in clinical blood samples, can interfere with the LAL cascade. Heparin inhibits endotoxin-dependent activation of the lysate by precipitating the proactivator proteins, an effect that can be reversed by increasing salt concentration in the reaction mix but still requires awareness during sample preparation.13Thrombosis and Haemostasis. Heparin Inhibition of Endotoxin-Dependent Limulus Amebocyte Lysate Coagulation
The Horseshoe Crab Problem
Every vial of LAL reagent starts with horseshoe crab blood. The biomedical industry bleeds hundreds of thousands of horseshoe crabs each year, collecting about 30% of each animal’s blood before returning them to the ocean. The process leaves thousands dead annually, and it has broader ecological consequences. Horseshoe crab populations and the shorebird species that depend on horseshoe crab eggs during spring migration are both in decline.14PubMed Central. Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection
Even among crabs that survive bleeding and are returned to the water, the process takes a toll. Research tracking female horseshoe crabs after biomedical bleeding found that while their overall activity levels and seasonal movement patterns appeared normal, bled females attempted to spawn about half as often as unbled controls in the weeks following the procedure.15Marine Ecology Progress Series. Impacts of biomedical bleeding on locomotion and mating behavior in the horseshoe crab Limulus polyphemus Reduced spawning directly translates to fewer eggs on beaches, which means less food for migratory shorebirds like the red knot.
Alternatives Moving Away From Horseshoe Crabs
Conservation pressure and supply-chain concerns have pushed the development of synthetic alternatives. The most prominent is the recombinant Factor C (rFC) assay, which uses a lab-engineered version of the same Factor C protein that horseshoe crab amebocytes produce. Because rFC targets only the endotoxin-sensing pathway, it does not cross-react with beta-glucan the way traditional LAL does. Validation studies have shown that the rFC assay matches the accuracy of the LAL test for detecting reference standard endotoxin.16PubMed Central. A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals Some biopharmaceutical samples showed greater interference with rFC than with LAL, but diluting those samples resolved the problem. Separate work on veterinary autogenous vaccines found a statistically significant correlation between rFC and LAL results, supporting the synthetic assay’s use as a routine quality-control tool.17PubMed Central. Recombinant Factor C as an In Vitro Assay for the Residual Pathogenicity Evaluation of Veterinary Autogenous Vaccines
A different approach is the Monocyte Activation Test (MAT), which uses human blood cells to detect pyrogens. Unlike both the LAL and rFC assays, which respond only to endotoxin (or, in LAL’s case, endotoxin plus beta-glucan), the MAT detects a broader range of fever-causing substances, including non-endotoxin pyrogens such as certain bacterial cell-wall fragments that don’t contain LPS.18PubMed Central. Validation of the Monocyte Activation Test Demonstrating Equivalence to the Rabbit Pyrogen Test A review of evidence from published studies, unpublished data, and an international validation study concluded that the whole-blood MAT reliably detects non-endotoxin pyrogens.19PubMed. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test The MAT’s ability to catch pyrogens that slip past endotoxin-only assays makes it especially valuable for products like medical devices, where non-endotoxin contamination is a realistic concern.
Despite these advances, regulatory acceptance has been gradual. The European Pharmacopoeia was the first to include rFC and MAT as accepted methods, and the U.S. FDA has approved rFC for specific applications, but LAL remains the default in most global pharmacopeias. Changing a quality-control method in pharmaceutical manufacturing involves extensive revalidation, and many companies have been cautious about switching.
Standardizing the Measurement
Because endotoxin activity depends on the source bacterium and how the sample was prepared, the world needed a common yardstick. The World Health Organization maintains an International Standard for Endotoxin, which is a freeze-dried preparation of known potency against which all test reagents and in-house reference materials are calibrated. The current standard is the 3rd International Standard, with an assigned potency of 10,000 International Units per vial. Its production involved a collaborative study confirming that both gel-clot and photometric LAL methods produced comparable potency estimates.20PubMed. Collaborative study for the establishment of the WHO 3rd International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354 One International Unit equals one FDA/USP Endotoxin Unit, a relationship established during calibration of the 2nd International Standard in a study involving 26 scientists across 13 countries.21Journal of Endotoxin Research. Second international standard for endotoxin: calibration in an international collaborative study This global standardization is what allows an endotoxin limit set in one country’s pharmacopeia to mean the same thing in another’s laboratory.
Endotoxin Beyond the Lab
LPS testing is not confined to pharmaceutical clean rooms and hospital labs. Environmental and occupational health researchers measure airborne endotoxin in workplaces where organic dust is common. In agricultural settings, workers exposed to high levels of airborne LPS from grain dust, animal waste, and composting operations face increased risk of respiratory inflammation and accelerated lung-function decline.22PubMed Central. Environmental endotoxin exposure and asthma Indoor-air quality studies in homes, schools, and office buildings also use LAL-based assays to quantify endotoxin in settled dust, since elevated household endotoxin has been linked to wheezing and asthma symptoms, particularly in children.
A related but distinct concept is metabolic endotoxemia, which refers to mildly elevated LPS levels in the blood that are not caused by an obvious infection. The theory is that LPS from gut bacteria leaks into the bloodstream when the intestinal barrier is compromised, a state sometimes called “leaky gut.” This low-grade endotoxin exposure has been proposed as a contributor to chronic inflammation and is being studied in connection with obesity, type 2 diabetes, non-alcoholic fatty liver disease, and even neurodegenerative conditions.23PubMed Central. Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors Measuring LPS in serum for metabolic endotoxemia research uses the same basic assay principles as pharmaceutical testing, but the clinical significance of small elevations is still being worked out. It is an area where the testing technology is ahead of the clinical consensus on what the numbers mean.